911±¬ÁÏÍø

Application note

Producing 3D Neuronal Microtissues for Preclinical Drug Screening using ioGlutamatergic Neurons

In this application note, ioGlutamatergic neurons and iPSC-derived astrocytes are used in 3D microtissues, created with the RASTRUMâ„¢ 3D cell culture platform. The platform supports both 96- and 384-well formats and mimics key CNS features like neurite outgrowths. This offers a powerful model system for medium- to high-throughput drug screening and more productive preclinical drug development.
Producing 3D Neuronal Microtissues for Preclinical Drug Screening using ioGlutamatergic Neurons
In this application note, ioGlutamatergic neurons and iPSC-derived astrocytes are used in 3D microtissues, created with the RASTRUMâ„¢ 3D cell culture platform. The platform supports both 96- and 384-well formats and mimics key CNS features like neurite outgrowths. This offers a powerful model system for medium- to high-throughput drug screening and more productive preclinical drug development.

3D cell culture models using human induced pluripotent stem cells (iPSCs) have emerged as a promising, human relevant model system for the study of central nervous system (CNS) disorders. Unlike two-dimensional cell culture, 3D cultures achieve physiological relevance by culturing cells in a 3D environment with many of the factors that influence cell behavior in vivo. However, the complexity of iPSC differentiation has hindered adoption of these models for high-throughput drug screening, leaving researchers to rely on 2D models with poor predictive validity. ioCellsâ„¢ from 911±¬ÁÏÍø, generated through opti-oxâ„¢ technology, provide a solution by using deterministic cell programming to consistently generate mature human neuronal cells at scale.

Herein, we delve into a recent study using the RASTRUMâ„¢ 3D cell culture platform from Inventia Life Science to generate neuronal microtissues composed of ioGlutamatergic neurons and iPSC-derived astrocytes. The microtissues are formed within a composite hydrogel scaffold mimicking key CNS microenvironmental features. These 3D co-cultures, formed in both 96- and 384-well plate formats, exhibited mature neuronal phenotypes with characteristic neurite outgrowths. Such a model offers a robust and scalable system for medium- to high-throughput drug discovery assays, thereby enabling more productive preclinical drug development. 

In this application note, you will discover: 

  • How ioCells enable 3D co-culture of mature human neurons
  • How neuronal microtissues can be built en masse using ioCells and the RASTRUM 3D cell culture platform
  • Characteristics of human iPSC-derived neuronal microtissues that may be of value in medium- to high-throughput drug screening.
V1
2024
911±¬ÁÏÍø
Inventia

Related pages

News Read our latest updates and press coverage
Our platform Discover the cell coding platform behind our cells
Join us Explore the latest roles at 911±¬ÁÏÍø